CSBR:NASDAQ
Champions Oncology Inc
$4.40
arrow_downward
-0.90%(-0.040) 1D
Nov 19, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.47
High
$4.47
Low
$4.40
Mkt. cap
61.24M
Avg. vol.
6.90K
Volume
4.87K
52-wk high
$8.31
52-wk low
$4.40
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.47
High
$4.47
Low
$4.40
Mkt. cap
61.24M
Avg. vol.
6.90K
Volume
4.87K
52-wk high
$8.31
52-wk low
$4.40
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
The Semiconductor ETF Is on Track to Beat the S&P 500 for a 4th Straight Year. It Has Never Done That Before.
FXStreet
·
2 hours ago
Dow Jones Industrial Average falls over 1,000 points as Anthropic IPO dominates
Traders Union
·
2 hours ago
S&P 500 sees $2 trillion swing and 8.5 percent drop, Peter Tuchman notes
ChartMill
·
2 hours ago
S&P 500 After-Hours Movers: Nov. 19, 2026
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com